Eli Lilly’s phase three trial of its monoclonal antibody treatment for coronavirus has been paused due to potential safety concerns. This comes shortly after Johnson and Johnson and AstraZeneca also paused its Covid-19 clinical trials. Michael…
Eli Lilly’s phase three trial of its monoclonal antibody treatment for coronavirus has been paused due to potential safety concerns. This comes shortly after Johnson and Johnson and AstraZeneca also paused its Covid-19 clinical trials. Michael…